Nuclear FGFR2 was recently found to negatively regulate hypoxia-induced cell invasion in prostate cancer [187] and nuclear FGFR1 was positively corelated with pancreatic and breast cancer progression [178,179]. This evidence concerns the gene FGFR2 and breast cancer.